Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up 0.21% Nasdaq Up 0.26%
Streaming
Ticker Tape: On

Dyax Corp. (DYAX)

-NasdaqGM
6.79 Up 0.06(0.89%) 9:57AM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Prev Close:6.73
Open:6.78
Bid:6.75 x 400
Ask:6.78 x 300
1y Target Est:13.36
Beta:1.07
Next Earnings Date:30-Apr-14DYAX Earnings announcement
Day's Range:6.70 - 6.80
52wk Range:2.26 - 10.99
Volume:86,246
Avg Vol (3m):1,610,210
Market Cap:855.98M
P/E (ttm):N/A
EPS (ttm):-0.26
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DYAXUp 0.89%855.98M
SHPGUp 1.45%27.81B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Mar-14) :-0.05
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-7.65

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and plasma kallikrein-mediated (PKM) angioedemas. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback